Global Wholehealth Partners (OTCMKTS:GWHP) vs. MariMed (OTCMKTS:MRMD) Critical Comparison

Global Wholehealth Partners (OTCMKTS:GWHP) and MariMed (OTCMKTS:MRMD) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability.

Insider & Institutional Ownership

0.2% of MariMed shares are owned by institutional investors. 10.3% of Global Wholehealth Partners shares are owned by insiders. Comparatively, 17.3% of MariMed shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Global Wholehealth Partners and MariMed”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global Wholehealth Partners	N/A	N/A	N/A	($0.05)	N/A
MariMed	$159.83 million	0.17	-$14.48 million	($0.03)	-2.33

Global Wholehealth Partners has higher earnings, but lower revenue than MariMed. MariMed is trading at a lower price-to-earnings ratio than Global Wholehealth Partners, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Global Wholehealth Partners and MariMed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Global Wholehealth Partners	N/A	N/A	N/A
MariMed	-7.82%	-5.00%	-1.29%

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Global Wholehealth Partners and MariMed, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global Wholehealth Partners	0	0	0	0	0.00
MariMed	0	2	0	0	2.00

Given Global Wholehealth Partners’ higher probable upside, equities research analysts clearly believe Global Wholehealth Partners is more favorable than MariMed.

Summary

MariMed beats Global Wholehealth Partners on 5 of the 9 factors compared between the two stocks.

About Global Wholehealth Partners

Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic (IVD) test kits in the United States. The company offers approximately 125 diagnostic tests kits for over-the-counter or consumer-use, as well as for point-of-care, which includes hospitals, physicians' offices, and medical clinics. It provides tests for various diseases, such as Ebola, zika, dengue, malaria, influenza, tuberculosis, coronaviruses, yellow fever, and other epidemic and vector-borne diseases. The company was incorporated in 2013 and is based in Newport Beach, California.

About MariMed

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.